Foghorn Therapeutics, Inc. (FHTX) Social Stream
FOGHORN THERAPEUTICS INC (FHTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering FOGHORN THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 3 | $24 | $23 | $23.5 | $5.6 | 319.64% |
| 2021-11-22 | 3 | $25 | $23 | $24 | $5.6 | 328.57% |
| 2021-11-30 | 4 | $25 | $23 | $24 | $5.6 | 328.57% |
| 2021-12-13 | 4 | $32 | $23 | $26.666 | $5.6 | 376.18% |
| 2022-05-10 | 4 | $32 | $25 | $27.666 | $5.6 | 394.04% |
| 2022-05-20 | 4 | $32 | $18 | $25 | $5.6 | 346.43% |
| 2022-08-10 | 5 | $32 | $18 | $24 | $5.6 | 328.57% |
| 2022-08-12 | 5 | $32 | $21 | $25.75 | $5.6 | 359.82% |
| 2022-11-09 | 5 | $25 | $15 | $21.5 | $5.6 | 283.93% |
| 2022-11-21 | 5 | $25 | $14 | $21.25 | $5.6 | 279.46% |
| 2023-03-10 | 6 | $25 | $14 | $21 | $5.6 | 275% |
| 2023-04-24 | 7 | $25 | $10 | $18.166 | $5.6 | 224.39% |
| 2023-05-08 | 7 | $25 | $10 | $17.166 | $5.6 | 206.54% |
| 2023-05-10 | 7 | $20 | $10 | $15.2 | $5.6 | 171.43% |
| 2023-06-28 | 6 | $20 | $11 | $15.4 | $5.6 | 175% |
| 2023-06-29 | 7 | $20 | $11 | $15.833 | $5.6 | 182.73% |
| 2023-11-06 | 7 | $20 | $10 | $15.333 | $5.6 | 173.8% |
| 2023-11-10 | 7 | $20 | $6 | $14.666 | $5.6 | 161.89% |
The Trend in the Analyst Price Target
FHTX's average price target has moved down $6.83 over the prior 15 months.
FHTX reports an average of 189.88% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-05 | 6 | 25 | 14 | 21.000 | 6.45 | 225.58% |
| 2023-03-10 | 6 | 25 | 13 | 19.800 | 5.30 | 273.58% |
| 2023-04-24 | 7 | 25 | 10 | 18.166 | 6.19 | 193.47% |
| 2023-06-08 | 6 | 20 | 11 | 15.400 | 8.10 | 90.12% |
| 2023-08-07 | 7 | 20 | 10 | 15.333 | 9.24 | 65.94% |
FHTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.29 | 6 | 0 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 20 months, FHTX's average broker recommendation rating worsened by 0.04.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how FOGHORN THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2145.32% of that group.
- To contextualize these metrics, consider that out of all US stocks, FOGHORN THERAPEUTICS INC's number of analysts covering the stock is greater than 584.73% of them.
- In the context of all US stocks, FOGHORN THERAPEUTICS INC's average analyst price target is higher than 611.36% of them.
- FHTX has a lower variance in analysts' estimates than -1300.14% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to FOGHORN THERAPEUTICS INC are PRTC, NBTX, and GRCL.
View All Top Stocks by Price Target
What is the outlook for FHTX? Use POWR Ratings for clearer insight into price direction.